insights_auto
Istiqbol: 63.3% optimistik·3.3% pessimistik
Tahlilga kirishchevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,46 US$
arrow_downward
-1,02%(-0,015) 1K
1,41 US$
arrow_downward
-3,42% (-0,050)bedtimeYopilgandan keyin
Savdolar yopilgan: 12-noy, 16:00:01 (GMT-5) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoINO tikeri uchun statistika yaratilmoqda...
Ochish
1,44 US$
Yuqori
1,53 US$
Past
1,33 US$
Bozor kapitali
272,54 mln
Oʻrtacha hajm
19,06 mln
Hajmi
0,00
52 haftalik eng yuqori
2,72 US$
52 haftalik eng past
0,56 US$
Aksiya boʻyicha daromad
-1,17 US$
Beta
1,71
Muomaladagi aksiyalar
187,31 mln
Xodimlar soni
112
Ochish
1,44 US$
Yuqori
1,53 US$
Past
1,33 US$
Bozor kapitali
272,54 mln
Oʻrtacha hajm
19,06 mln
Hajmi
0,00
52 haftalik eng yuqori
2,72 US$
52 haftalik eng past
0,56 US$
Aksiya boʻyicha daromad
-1,17 US$
Beta
1,71
Muomaladagi aksiyalar
187,31 mln
Xodimlar soni
112
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
News Corp
·
8 soat oldin
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
MarketWatch
·
8 soat oldin
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors
GuruFocus
·
19 soat oldin
Inovio Pharmaceuticals Inc (INO) (Q3 2026) Earnings Call Highlig
Yahoo Finance
·
1 kun oldin
Inovio Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary
Profil
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
Inovio Pharmaceuticals Inc haqida
CEOJacqueline Shea
Xodimlar soni112
Asos solingan1999
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytinovio.com